MOLECL is a precision glycosylation detection for Pharma QC. Using solid-state nanopores and site-specific molecular probes, we do digital, single-molecule readouts at defined protein sites in<1hour. First target: Asn297 on IgG1 Fc, the key CQA for ADCC function and FDA/EMA lot release. Current standard (LC-MS) takes days and costs ~$10K per run. MOLECL replaces this with a fast RUO QC solution Validated at EPFL, >1M CHF non-dilutive funding secured. Pilots active with Evitria AG and GlycoEra AG